Profund Advisors LLC Veracyte, Inc. Transaction History
Profund Advisors LLC
- $2.59 Billion
- Q3 2024
A detailed history of Profund Advisors LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Profund Advisors LLC holds 18,711 shares of VCYT stock, worth $770,518. This represents 0.02% of its overall portfolio holdings.
Number of Shares
18,711
Previous 21,081
11.24%
Holding current value
$770,518
Previous $456,000
39.47%
% of portfolio
0.02%
Previous 0.02%
Shares
7 transactions
Others Institutions Holding VCYT
# of Institutions
307Shares Held
81.7MCall Options Held
134KPut Options Held
13.3K-
Black Rock Inc. New York, NY7.79MShares$321 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.75MShares$319 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.02MShares$207 Million0.27% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.92MShares$203 Million1.59% of portfolio
-
Wellington Management Group LLP Boston, MA4.23MShares$174 Million0.03% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.95B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...